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Purpose: Uveitis is the third leading cause of blindness worldwide. This study aimed to
summarize the pattern of uveitis in Iran through a systematic review.
Methods: This review was conducted according to the guidelines for systematic reviews
in the following four steps: literature search, study selection and assessment, inclusion
and exclusion criteria, and statistical analysis.
Results: One hundred and fifteen articles were identified by an encyclopedic literature
search, and three independent investigators examined them according to the defined
inclusion and exclusion criteria. Eventually, 109manuscripts were retrieved and six cross-
sectional studies covering 3,567 patients were included and reviewed. According to the
results, the mean age of patients was 40 years, and sex was not a statistically significant
predisposing factor. The most common anatomical pattern of involvement was anterior
uveitis, and the prevalence of the other three types of uveitis, includingmiddle, posterior,
and pan-uveitis, were almost equal. Overall, the most common etiologies of uveitis in the
Iranian population were idiopathic uveitis, toxoplasmosis, Behcet’s syndrome, and Fuchs
heterochromic iridocyclitis.
Conclusion: This study depicted the pattern of uveitis in the Iranian society; this can help
physicians in the diagnostic approach, management, and treatment of patients.
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INTRODUCTION
Uveitis is an umbrella term that includes a wide
spectrum of intraocular inflammatory conditions in
which the various parts of the eye may be attacked
by the immune system.[1]
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Uveitis refers to inflammation of the uveal
tract (iris, ciliary body, and choroid); however,
retina, vitreous body, optic nerve, and sclera
may also be involved.[2] The etiology of the
disease is categorized into traumatic, infectious,
and noninfectious-immunologic causes and
masquerade syndromes.[3, 4]
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Noninfectious-immunologic uveitis comprises
vision-threatening diseases that can be associated
with systemic or ocular autoimmune disease, with
specific or unknown etiology.[5]
More than two million patients worldwide have
uveitis,[1] and it has an estimated incidence of
17–52/100,000 person-years. Approximately 35%
of these individuals experience severe visual
loss and legal blindness[2] and it is the third
leading cause of blindness (approximately 5–
10% worldwide).[1, 6, 7] Intermediate, posterior, and
pan-uveitis are responsible for visual disabilities
in most of these patients. The most common
sight-threatening complications are macular
edema, retinal detachment, retinal vasculitis,
and optic neuropathy. Other causes include
phthisis bulbi, hypotony,[8] band keratopathy, and
glaucoma.[1]
The prevalence, phenotypic features, and
distribution of different types of uveitis depend on
genetic and epidemiologic factors such as age,
sex, race, geographic and environmental influence,
and social habits.[6, 9] Uveitis may occur in any age
group, from infancy to adulthood, but individuals
aged 20–60 years old are more susceptible (the
incidence in adults is approximately fivefold of
that in children).[2] Global studies have found
anterior uveitis to be the most common type of
involvement seen in both adults and children, but
the underlying etiologies differ; for example,
juvenile idiopathic arthritis ( JIA)-associated
uveitis is more common in children and HLA-
B27-associated uveitis predominantly affects
young adults.[9]
In most studies, male and female patients
were equally affected.[3, 10] However, some causes
are more prevalent in a particular gender; for
example, HLA-B27-associated anterior uveitis is
more common among male patients,[2] and JIA-
associated uveitis and multiple sclerosis (MS)-
associated intermediate uveitis are more common
in young girls.[11–13]
The epidemiology of non-infectious uveitis is
more dependent on racial rather than regional
features.[14] The prevalence of infectious uveitis
(estimated at 30–50% of all uveitis cases)
and some non-infectious posterior uveitis,
such as Behcet’s and Vogt-Koyanagi-Harada
(VKH) syndrome, is higher in developing
countries.[4, 15, 16] Common infectious causes
include toxoplasmosis,[15, 17] tuberculosis (TB),
onchocerciasis, cysticercosis, leprosy, and
leptospirosis.[2] The prevalence of some causes
of non-infectious uveitis depends on the regional
area: for instance, sarcoidosis in Japan.[18]
Behcet’s disease in countries along the ancient
Silk Road (Iran, Turkey, China, Japan, Saudi
Arabia, and Greece),[9, 19] and VKH syndrome
in Asian or Eurasian countries.[18] Generally,
the prevalence of infectious uveitis is lower
in developed countries; common causes
are herpes virus and toxoplasmosis, while
other infections, such as TB and syphilis, are
rare.[4]
Ocular inflammation embraces a broad range of
pathologies, both with respect to its etiology and
the anatomical location within the eye. For proper
listing of the differential diagnosis, practitioners
should survey all important information, such as
the anatomical location of involvement, pathology
(granulomatous vs non-granulomatous), laterality
(unilateral vs bilateral), and chronicity (acute,
recurrent, or chronic) of the inflammation.[4] The
classification of uveitis helps physicians in the
diagnostic approach, management, and treatment
of patients.
To date, several classification systems have
been proposed that vary according to the
anatomical location of involvement (primary site
of the inflammation), clinical course, etiology, and
histopathology.[20, 21] Based on the Standardization
of Uveitis Nomenclature Working Group,[21]
the anatomical location of involvement is
classified into four types as follows: anterior,
intermediate, posterior, and pan-uveitis (Table 1).
This classification is widely accepted today and is
now the standard required for the publication of
uveitis studies in peer-reviewed literature.
The etiologic distribution of uveitis varies from
region to region and parallels that of many studies
that have investigated the pattern of uveitis in
different parts of the world. Most of the data in this
field are from the US and Europe, and reports from
developing countries are limited.[4, 14, 22] Today,
an acceptable number of reports that focus on
the epidemiology of uveitis in Iran are available;
however, all these studies have been conducted
in university-based ophthalmology centers. In this
study, we review all the available articles on the
epidemiology of uveitis in Iran to discuss novel
and interesting data regarding the pattern of the
disease.
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Table 1. Anatomical location of involvement in uveitis based on the Standardization of Uveitis Nomenclature (SUN) Working
Group
Type Primary site of inflammation Includes
Anterior uveitis Anterior chamber Iritis
Iridocyclitis
Anterior cyclitis
Intermediate uveitis Vitreous Pars planitis
Posterior cyclitis
Hyalitis





Panuveitis Anterior chamber, vitreous, and retina or choroid
METHODS
This review was conducted according to the
guidelines for systematic reviews in healthcare[23]
in four steps as described below (methodology
described in Figure 1):
Literature Search
An encyclopedic literature search for articles
published up to July 2019 was conducted on
MEDLINE, EMBASE, and the Cochrane library. No
language limitations were applied.
All studies that reported the epidemiology of
uveitis in Iranian patients were detected based on
the medical subject heading (MeSH) terms for the
following search strategy:
“{[(“Uveitis” or “Panuveitis” or “Ophthalmia,
Sympathetic” or “Uveitis, Anterior” or “Uveitis,
Posterior” or “Uveitis, Intermediate” or
“Pars Planitis” or “Uveitis, Suppurative” or
“Panophthalmitis”).af.] AND (ocular inflammation)
AND (iran.mp. [mp=ti, ot, ab, tx, ct, sh, kw, ps, sj,
do, dv, po, go, rs, nm, hw, an, ui])}.”
In addition, a broad literature search was
conducted using Persian databases such as
IranMedex (www.iranmedex.com), Scientific
Information Database (www.sid.ir), and MagIran
(www.magiran.com). A manual search was
performed in the following journals: Journal
of Ophthalmic and Vision Research (http:
//www.jovr.org), Journal of Current Ophthalmology
(https://www.journals.elsevier.com/journal-of-
current-ophthalmology), and Bina Journal of
Ophthalmology (binajournal.org).
Finally, the cited references in the obtained
studies were manually reviewed for relevant
articles. A total of 15 articles were found in this step.
Study Selection & Assessment
Articles that were most relevant to our topic
were selected, and among them, the reported
prevalence, incidence, or epidemiologic pattern of
uveitis were thoroughly studied.
Inclusion & Exclusion Criteria
Two researchers, M.B. (MD, ophthalmologist,
vitreoretinal surgeon) and A.J. (MD, general
ophthalmologist), independently assessed the
titles and abstracts identified in the previous
step for potential eligibility, and the full-
text articles were retrieved for studies on
the epidemiological pattern of uveitis in the
Iranian population. Fifty-nine studies were
found and all their full-text versions were
obtained. To avoid potential bias or errors,
three independent individuals, M.B., A.J., and
H.S.H. (MD, statisticians) examined the quality of
the papers separately according to the checklist
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Table 3. Common etiologies of uveitis in different types in studies carried out at tertiary ophthalmology referral centers in Iran
Study (First author) Ant. uveitis (%) Int. uveitis Post. uveitis Pan-uveitis (%) Total (%)




























(16.6 > VKH (10.6) >
Herpetic Uveitis (21) >
Seronegative
Spondyloarthropathy
(6.8) > FU (6.4)
Rahimi M, et al (2016)[27] Idiopathic (59) > JIA
(22.7) >
Posner-Schlossman (9)







Idiopathic (50) > VKH
(25) > Sympathetic
Ophthalmia (25)
Idiopathic (62.9) > JIA
(9.2) > Toxoplasmosis
(7.4) = Toxocariasis (7.4)
> Herpetic Uveitis (1.8)
Kianersi F, et al (2016)[28] Idiopathic (50.5) > FHI
(32.8) > Herpetic
Uveitis (7.6) > Behcet’s









> Idiopathic (32) > VKH




FHI (14.1) > Behcet’s
Syndrome (10.5) >
Herpetic Uveitis (3.2)
Rahimi M, et al (2014)[29] Idiopathic (44.2) > FHI
(17.8) > Seronegative
Spondyloarthropathy
(10) > Herpetic Uveitis
(7.8) = JIA (7.8)
Idiopathic (92.4) Toxoplasmosis (42.1) >
Behcet’s Syndrome
(15.7) > ARN (8.2) >
VKH (6) > Toxocariasis
(4.7)
Behcet’s Syndrome








(11.8) > FHI (7.1) > VKH
(5.2)
Soheilian M, et al (2004)[30] Idiopathic (52.1) > FHI
(17.2) > Seronegative
Spondyloarthropathy














(22.5) > VKH (15.2) >
Multifocal Choroiditis







(8.6) > FHI (6.6) > VKH
(3.9)
Ant. uveitis: anterior uveitis; Int. uveitis: intermediate uveitis; Post. uveitis: posterior uveitis
Literature 
Search 
•MEDLINE, Pubmed, Mbase and Cochrane ( n= 91)
•SID, Iran Medex, MagIran and Hand Search in Journals ( n= 17)             115 studies obtained




•Irrelevant Study Excluded ( n= 52 )
•Reviews  Excluded ( n= 3)                                 56 studies excluded




•Study  Extracted by Independent Investigators ( n= 51)
• 53 studies excluded
•Doplication Study Excluded ( n= 2)
Included
Study




•Illustration Funnel Plot and Forest Plot
•Overall Effect Size and Fixed-Effects Model
Figure 1. Themethodology of the study step by step. During an encyclopedic literature search and survey of relevant cited studies,
115 studies were found, where 56 were excluded in the second step (irrelevant studies, reviews, comments and letters). After
reviewing the inclusion and exclusion criteria, 53 more studies were excluded, and finally, 6 studies were included for statistical
analysis.
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Event rate and 95% CI 
 Ant. Uveitis    
 
Hosseini SM, et al (2018) [25]  0.370 0.311 0.434 
Alizadeh L, et al (2017) [26]  0.300 0.246 0.361 
Rahimi M, et al (2016) [27]  0.407 0.285 0.542 
Kianersi F, et al (2016) [28]  0.429 0.408 0.451 
Rahimi M, et al (2014) [29]  0.400 0.357 0.445 






 Int. Uveitis    
 
Hosseini SM, et al (2018) [25]  0.119 0.084 0.167 
Alizadeh L, et al (2017) [26]  0.601 0.538 0.661 
Rahimi M, et al (2016) [27]  0.333 0.221 0.468 
Kianersi F, et al (2016) [28]  0.193 0.177 0.211 
Rahimi M, et al (2014) [29]  0.112 0.086 0.143 






 Post. Uveitis    
 
Hosseini SM, et al (2018) [25]  0.043 0.023 0.077 
Alizadeh L, et al (2017) [26]  0.049 0.028 0.085 
Rahimi M, et al (2016) [27]  0.185 0.103 0.311 
Kianersi F, et al (2016) [28]  0.214 0.197 0.233 
Rahimi M, et al (2014) [29]  0.280 0.241 0.322 






 Pan-Uveitis    
 -1.00     -0.50     0.00    0.50    1.00 
Hosseini SM, et al (2018) [25] 
Alizadeh L, et al (2017) [26] 
Rahimi M, et al (2016) [27] 
Kianersi F, et al (2016) [28] 
Rahimi M, et al (2014) [29] 






















Figure 2. Pattern of uveitis based on anatomical location of involvement explained in this figure according to the studies separately.
Ant. uveitis: anterior uveitis; Int. uveitis: intermediate uveitis; Post. uveitis: posterior uveitis
for critical appraisal and data extraction for
systematic reviews of prediction modelling studies
(CHARMS).[24] Then, the data were extracted.
Discrepancies were resolved by a consensus
or discussion with the fourth reviewer, M.H.A.
(MD, ophthalmologist, vitreoretinal surgeon), if
necessary. Eventually, six cross-sectional studies
covering 3,567 patients and data extracted by
the investigators were included, and the final data
were matched.
Statistical Analysis
The following data were collected from each study:
the name of the first author, publication date, city or
academic center, duration of the study, number of
patients, demographic characteristics, anatomical
pattern of involvement, etc. (Table 2).
Data were analyzed using the Comprehensive
Meta-Analysis.2 (CMA.2) software. The
heterogeneity index was assessed using the
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I2 test. A random-effects model was employed if
the test revealed substantial heterogeneity (I2 >
50%). If non-significant (I2 ≤ 50%), a fixed-effects
model was used.[31] The level of significance for
both heterogeneity and the pooled effect was
adjusted at P < 0.05.
RESULTS
Of the nine studies that examined the
epidemiology of uveitis in the Iranian society, three
were excluded because two were duplicates[32, 33]
and one was conducted only in patients with
posterior uveitis.[34] Finally, data from six studies
were analyzed; two involved cases of pediatric
uveitis and four involved adults. Except for two
studies that examined pediatric uveitis (patients
enrolled in the age range <18 years),[26, 27] the
mean age of the patients included in the studies
was 40 years.[25, 28–30]. In all reports, the disease
was more common in women than in men, except
in the study by Hosseini et al, where this ratio was
statistically significant (female to male ratio was
1.5).[25]
Statistical analysis showed that the most
common anatomical pattern of involvement in
the tertiary referral ophthalmology centers was
anterior uveitis (event rate: 40.6% among all uveitis
patients), but the prevalence of the other three
types including middle, posterior, and pan-uveitis
was almost equal (because of the non-significant
I2, the fixed-effects model was used to estimate the
overall effect size; data not shown). In the majority
of studies, the most common anatomical site of
involvement was anterior uveitis[27–30] except in
the reports by Hosseini et al[25] (pan-uveitis was
prevalent in 110 out of 235 involved; 46.8%) and
Alizadeh-Ghavidel et al[26] (intermediate uveitis
was prevalent with 146 out of 243 involved; 60.1%).
The rarest anatomical site of involvement in three
studies was pan-uveitis;[26–28] however, this was
not the case in the reports by Hosseini et al[25]
(posterior uveitis was the rarest with 10 out of
235 cases involved; 4.25%), Rahimi et al,[29] and
Soheilian et al[30] (intermediate uveitis was the
rarest with 53 out of 475 cases [11.1%] and 96 out
of 544 cases [17.6%], respectively). The study-wise
pattern of uveitis based on the anatomical location
of involvement has been shown in Figure 2.
In most studies, binocular involvement was
more common, but in the studies by Hosseini
et al and Alizadeh-Ghavidel et al, monocular
involvement was more prevalent.[25, 26] In all
studies conducted in ophthalmology referral
centers, the most common type of pathological
involvement in patients was non-granulomatosis
uveitis (compared to the granulomatous type). The
prevalence of non-infectious uveitis in all studies
was higher than that of infectious uveitis, although
in the pattern of posterior uveitis, the infectious
type was more common than the non-infectious
type due to toxoplasma retinochoroiditis. Table
2 summarizes the uveitis pattern in the studies
carried out at tertiary ophthalmology referral
centers in Iran.
In the study by Hosseini et al, which was
conducted at an ophthalmology referral center in
north eastern Iran, idiopathic uveitis was more
common overall (67 cases of 235; 28.5%) and in
different uveitis types, except posterior uveitis in
which toxoplasma retinochoroiditis was prevalent
(3 cases, 10; 10%). After idiopathic uveitis, Behcet’s
syndrome (39 patients; 16.6%), VKH (25 patients,
10.6%), herpetic uveitis (21 patients, 8.9%), and
seronegative spondyloarthropathy (16 patients,
6.8%)[25] were the other common etiologies in
different uveitis types.
In the study by Alizadeh-Ghavidel et al, which
was conducted at an ophthalmology referral center
in the northwest of Iran, idiopathic uveitis was more
common overall (117 cases of 243; 48.1%), followed
by toxoplasma retinochoroiditis (5.3%).[26]
In the study by Kianersi et al, conducted
at an ophthalmology referral center in Iran,
idiopathic uveitis was more common overall (882
cases of 2016; 43.9%), followed by toxoplasma
retinochoroiditis (19.3%), Fuchs heterochromic
iridocyclitis (FHI) (14.1%), Behcet’s syndrome
(10.5%), and herpetic uveitis (3.2%).[28]
In the study by Rahimi et al, which was
conducted at an ophthalmology referral center in
southern Iran, idiopathic uveitis was more common
overall (180 cases of 475; 37.9%). Themost common
etiologies of idiopathic uveitis were Behcet’s
syndrome (12.4%), toxoplasma retinochoroiditis
(11.8%), FHI (7.1%), and VKH (5.2%).[29]
The first study on the epidemiology of uveitis in
the Iranian population was reported by Soheilian
et al in 2004 at a tertiary referral center in Tehran.
Similar to other studies, idiopathic uveitis was the
most common type of involvement (231 patients
out of 544; 45.5%). Other prevalent etiologies
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in different uveitis types were toxoplasma
retinochoroiditis (10.1%), Behcet’s syndrome (8.6%),
FHI (6.6%), and VKH (3.9%).[30] Table 3 shows the
common etiologies of uveitis in different types
of studies carried out at tertiary ophthalmology
referral centers in Iran.
DISCUSSION
Uveitis as a potentially sight-threatening ocular
disease poses diagnostic and therapeutic
challenges for general ophthalmologists as
well as uveitis specialists. Epidemiological studies
of the pattern and etiologies of uveitis can help
clinicians diagnose, manage, and treat the disease.
However, epidemiological studies on the disease
at a national level can aid in assessing the burden
of the disease on the country’s health community,
making it possible to plan for the future. In contrast,
studies on the incidence and prevalence of uveitis
in our society are limited, especially in the general
population. Based on the extensive literature
review, to the best of our knowledge, no study
has reported the epidemiological pattern of
uveitis in the general Iranian population, and no
study has been conducted in the field of general
ophthalmology (all reports were from referral
tertiary ophthalmology centers).
The clinical pattern of uveitis may change
over time for several reasons such as emerging
diseases, new surgical procedures that can lead
to uveitis as a complication, and new laboratory
equipment that may help to better understand
or further diagnose the disease. Certainly, the
limitations of laboratory equipment can make it
difficult to detect some etiologies and cause some
specific diagnosis to fall into the category of
idiopathic uveitis. Thus, the pattern of uveitis in
one community may be different from that in other
societies and may also change over time. This
justifies the need for national and regional studies
and repeated epidemiological studies over time.
Comparison of these studies could help identify the
predisposing factors in different regions, provide
new insights into the pathogenesis of the disease,
and clarify the path for future studies.
In the present study, the mean age of the
patients included in the articles reviewed was
40 years, and gender was not a statistically
significant predisposing factor. The most common
anatomical pattern of involvement was anterior
uveitis. However, the prevalence of the other
three types including middle, posterior, and pan-
uveitis was almost equal. Themost common clinical
features of the disease were binocular uveitis
(compared to the monocular), non-granulomatosis
uveitis (compared to the type of granulomatosis),
and non-infectious (compared to the infectious)
involvement. Overall, the prevalent etiologies
were idiopathic uveitis, toxoplasmosis, Behcet’s
syndrome, and FHI. In the subgroup analysis,
the most common etiologies for anterior uveitis
were idiopathic uveitis, FHI, and herpetic uveitis;
for intermediate uveitis, Behcet’s syndrome and
MS were common; and for posterior uveitis
toxoplasmosis, idiopathic uveitis and Behcet’s
syndrome were common. In pan-uveitis, Behcet’s
syndrome, idiopathic uveitis, and VKH syndrome
were most prevalent.
All published studies have examined the
epidemiology of uveitis in university referral
ophthalmology centers. Therefore, the results of
this study cannot be generalized to the public
because there are significant differences between
the pattern of disease in these studies compared to
general ophthalmology practice or the community.
Similar to the present study, most worldwide
reports have shown that anterior uveitis is the most
common type of involvement, followed by pan-
uveitis, posterior, and intermediate uveitis.[1, 9, 35, 36]
However, most of these studies have been carried
out in university referral centers, and their results
cannot be applied to the general public. In these
settings, a higher proportion of patients with
posterior and pan-uveitis and a lower proportion
of those with anterior uveitis are expected to be
comparable.[4, 37]
The pattern of uveitis can be influenced by
several epidemiologic factors; therefore, any
comparison should consider these differences.
The regional-based epidemiological studies can
be useful for both diagnostic and therapeutic
guidance. This may be more important in
developing countries such as Iran because of
its resource constraints and a higher prevalence
of the disease in some uveitic entities (compared
to developed countries), and its complications,
especially blindness.[4, 22, 38–40]
This study has some limitations. First, this study
was limited by the inclusion and exclusion criteria
of the studies reviewed; for example, all studies
considered traumatic uveitis as exclusion criteria,
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while Das et al reported a prevalence of 5%.[35]
Second, reports on the epidemiology of uveitis in
Iran have covered different time periods that may
be difficult to compare. Even in a single community,
the pattern of uveitis can change over time
for several reasons such as emerging diseases,
advances in laboratory equipment, and changes
in diagnostic criteria. However, when comparing
studies from different cities, some factors such
as the socioeconomic level of the region, can
change the face of the disease. In under-resourced
areas, an underrepresentation of mild or moderate
cases of uveitis is expected because of limited
access to medical facilities.[4, 22, 38–40] Third, this
study was limited by the inclusion of all types of
uveitis and different age ranges; considering the
heterogeneity in the selected studies and the non-
representative population, aggregate estimates for
the prevalence of uveitis could not be made in
the current review. However, according to the
survey in the Iranian population, the heterogeneity
of patients in terms of racial factors compared
to other global studies was minimal. Finally, the
survey of the referral centers may have been
influenced by referral bias; therefore, they do
not reflect an appropriate view of the disease
pattern in society or in general practice. Therefore,
subsequent analysis focusing on homogeneous
age groups can provide more accurate results
regarding the pattern of uveitis. In addition, future
epidemiologic studies are recommended in the
general population and in the field of general
ophthalmology.
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